Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoshu Bi

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Molecular Therapy. Nucleic Acids|May 4, 2022
miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathwaysGuoshu Bi, Jiaqi Liang, Mengnan Zhao, et al.
Respiratory Research|May 19, 2025
Transcription factor ZNF266 suppresses cancer progression by modulating CA9-mediated intracellular pH alteration in lung adenocarcinomaShencheng Ren, Junkan Zhu, Guangyao Shan, et al.
Oncogenesis|October 26, 2021
Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapyZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
Nature Communications|March 20, 2024
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancerGuoshu Bi, Jiaqi Liang, Yunyi Bian, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 1, 2026
A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinomaLu Gan, Qihai Sui, Mi-Die Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancerYiwei Huang, Zhencong Chen, Tao Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
NDRG1-Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive MicroenvironmentGujie Wu, Hongxia Cheng, Jiacheng Yin, et al.
Clinical and Translational Medicine|March 30, 2021
Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
International Journal of Biological Sciences|June 19, 2020
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinomaZhencong Chen, Xiaodong Yang, Guoshu Bi, et al.
Cell Death & Disease|April 20, 2026
Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinomaJiaqi Liang, Yanjun Yi, Junkan Zhu, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Molecular Therapy. Nucleic Acids|May 4, 2022
miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathwaysGuoshu Bi, Jiaqi Liang, Mengnan Zhao, et al.
Respiratory Research|May 19, 2025
Transcription factor ZNF266 suppresses cancer progression by modulating CA9-mediated intracellular pH alteration in lung adenocarcinomaShencheng Ren, Junkan Zhu, Guangyao Shan, et al.
Oncogenesis|October 26, 2021
Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapyZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
Nature Communications|March 20, 2024
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancerGuoshu Bi, Jiaqi Liang, Yunyi Bian, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 1, 2026
A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinomaLu Gan, Qihai Sui, Mi-Die Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancerYiwei Huang, Zhencong Chen, Tao Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
NDRG1-Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive MicroenvironmentGujie Wu, Hongxia Cheng, Jiacheng Yin, et al.
Clinical and Translational Medicine|March 30, 2021
Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
International Journal of Biological Sciences|June 19, 2020
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinomaZhencong Chen, Xiaodong Yang, Guoshu Bi, et al.
Cell Death & Disease|April 20, 2026
Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinomaJiaqi Liang, Yanjun Yi, Junkan Zhu, et al.
Pageof 8